Carbon Monoxide (CO) Poisoning

Etiology and Sources of Exposure

• Carbon monoxide (CO) is a colorless, odorless gas that poses a significant pediatric environmental hazard.
• It is generated during the incomplete combustion of any carbon-containing fuel; a less efficient combustion process produces correspondingly greater amounts of CO.
• Common sources of pediatric CO exposure include wood-burning stoves, kerosene heaters, poorly maintained or old furnaces, hot-water heaters, automobile exhaust, and closed-space fires.

Pathophysiology

• CO produces toxicity through multiple complex mechanisms, extending beyond simple displacement of oxygen from hemoglobin.
• Hemoglobin Binding: CO binds to the hemoglobin molecule with an affinity that is $>200$ times greater than that of oxygen.
• This binding forms carboxyhemoglobin ($HbCO$), which physically displaces oxygen and reduces the total oxygen-carrying capacity of the blood.
• The formation of $HbCO$ simultaneously induces a conformational change in the hemoglobin tetramer, causing a leftward shift of the oxygen-hemoglobin dissociation curve. This shift tightly binds the remaining oxygen, severely impairing its release to peripheral tissues and leading to profound tissue hypoxia.
• Cellular Toxicity: The severity of CO toxicity and $HbCO$ levels often do not correlate perfectly, primarily because CO also interacts with other critical non-hemoglobin proteins.
• CO directly binds to cytochrome oxidase within the mitochondrial electron transport chain, significantly disrupting oxidative phosphorylation and cellular respiration.
• Vascular and Free Radical Damage: CO displaces nitric oxide ($NO$) from intracellular proteins.
• The liberated $NO$ acts as a potent systemic vasodilator, which is largely responsible for acute clinical symptoms such as headache, syncope, and hypotension.
• Furthermore, the free $NO$ interacts with other free radicals to form peroxynitrite, a highly reactive and toxic molecule that triggers intense lipid peroxidation, leading to extensive endothelial and cellular damage.

Clinical Manifestations

• The clinical presentation of CO poisoning is highly variable and depends on the concentration and duration of exposure, making it a diagnostic challenge.
• Early/Mild Toxicity: Initial symptoms are often vague and nonspecific, classically including headache, malaise, nausea, and vomiting. Because of this nonspecific presentation, CO poisoning is frequently misdiagnosed as a viral illness (flu) or food poisoning.
• Moderate Toxicity: As exposure increases, patients may present with significant mental status changes, confusion, agitation, impaired judgment, ataxia, and syncope. Tachycardia and tachypnea are prominent compensatory responses.
• Severe Toxicity: Massive or prolonged exposure manifests as deep coma, seizures, severe metabolic acidosis, myocardial ischemia, cardiovascular collapse, and ultimately death.
• Atypical Toxidrome Features: Patients may occasionally exhibit hypothermia due to impaired cellular respiration.

Differential Diagnosis

• Infectious/Gastrointestinal: Viral gastroenteritis, influenza, or food poisoning (frequently confused due to nausea, vomiting, and malaise clusters in families).
• Other Toxic Gases: In the setting of a closed-space fire, simultaneous hydrogen cyanide ($HCN$) poisoning must be strongly suspected. A severe lactic acidosis (serum lactate $>10$ $mmol/L$) in a fire victim is highly suggestive of concomitant cyanide toxicity.

Diagnostic Evaluation

• Pulse Oximetry: Standard bedside pulse oximetry ($Sp{O}_2$) is notoriously unreliable and misleading in the setting of CO poisoning. Standard two-wavelength oximeters cannot differentiate between oxyhemoglobin and carboxyhemoglobin, frequently displaying a falsely reassuring, normal oxygen saturation ($>95\mathrm{\%}$) despite life-threatening tissue hypoxia.
• Blood Gas and Co-oximetry: The definitive diagnostic test is an arterial or venous blood gas analyzed with co-oximetry to directly measure the $HbCO$ fraction. CO toxicity and tissue hypoxia must be assumed until $HbCO$ levels are documented to be $<10\mathrm{\%}$.
• Cardiac Evaluation: Because the myocardium is highly sensitive to hypoxia, an electrocardiogram (ECG) and cardiac troponin levels should be obtained in any patient exhibiting cardiovascular symptoms, syncope, or severe poisoning to evaluate for myocardial ischemia.
• Other Biomarkers: A serum creatine kinase (CK) level should be evaluated in severely poisoned or comatose patients to screen for rhabdomyolysis resulting from prolonged immobility or tissue hypoxia.
• Pregnancy Screening: A pregnancy test is mandatory for all adolescent females, as fetal hemoglobin has a higher affinity for CO, putting the fetus at an extreme risk of anoxic injury even at lower maternal $HbCO$ concentrations.

Management

• Initial Resuscitation: Immediate removal of the victim from the source of exposure is the first step. Priority is given to securing the airway, maintaining breathing, and supporting circulation (ABCs). Endotracheal intubation may be required for patients with a severely depressed sensorium or those unable to protect their airway.
• Normobaric Oxygen Therapy: The cornerstone of treatment is the immediate administration of $100\mathrm{\%}$ oxygen via a tight-fitting non-rebreather face mask (or via an endotracheal tube if intubated).
• Breathing $100\mathrm{\%}$ oxygen drastically accelerates the elimination of CO. While the half-life of $HbCO$ in ambient room air is approximately $4$ to $6$ hours, the administration of $100\mathrm{\%}$ normobaric oxygen reduces this half-life to $40$ to $90$ minutes.
• Normobaric oxygen therapy should be continuously provided until the patient is completely asymptomatic and the measured $HbCO$ level falls below $10\mathrm{\%}$.
• Hyperbaric Oxygen (HBO) Therapy: In severe cases, HBO therapy is utilized to further accelerate CO elimination and potentially minimize long-term neurological damage.
• HBO delivers $100\mathrm{\%}$ oxygen at elevated atmospheric pressures (typically $2$ to $3$ atm), which dissolves additional oxygen directly into the plasma and further dramatically decreases the $HbCO$ half-life to just $20$ to $30$ minutes.
• The primary goal of HBO is not only acute resuscitation but the prevention of delayed neuropsychiatric sequelae.
• Indications for HBO Therapy: Referral for hyperbaric oxygen should be strongly considered for high-risk patients. Accepted indications include:
  • History of syncope or loss of consciousness.
  • Coma or seizures.
  • Persistent altered mental status or confusion.
  • Objective evidence of myocardial ischemia (ECG changes or elevated troponin).
  • An $HbCO$ level $>25\mathrm{\%}$ in any patient.
  • An $HbCO$ level $>15\mathrm{\%}$ in a pregnant patient (due to the high vulnerability of the fetus).
  • Abnormal cerebellar examination findings (e.g., ataxia).
• Consultation with a medical toxicologist or a regional Poison Control Center is highly recommended to guide the specific indications and logistics of HBO transfer.

Long-Term Complications

• Patients surviving acute CO poisoning remain at significant risk for delayed neurologic sequelae.
• These complications may manifest days to weeks after apparent recovery and typically involve persistent cognitive deficits, memory impairment, personality changes, and delayed cerebellar effects.